Capstone Capital Management Ltd

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 2069260 HONG KONG, K3

Position in ALNY

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$318,188

-$266,459 QoQ

Shares Held

1,057

-40.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

#538

of 784 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Capstone Capital Management Ltd holds $1,120,063 across 3 Biotechnology names. ALNY ranks #2 (28.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NKTR	Nektar Therapeutics	7,066	$493,277
2	ALNY	Alnylam Pharmaceuticals, Inc. This page	1,057	$318,188
3	WVE	Wave Life Sciences, Inc.	53,115	$308,598

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$318,188	1,057	-40.2%	Shares	Sole	2026-07-20
2026-03-31	$584,647	1,767	-23.2%	Shares	Sole	2026-04-30
2025-12-31	$914,992	2,301	—	Shares	Sole	2026-02-06
No filing history on record for this holder in this stock.